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Abstract
 
Several reports have implicated reactive oxygen and nitrogen metabolites (RONS) in the initi-
ation and/or progression of inflammatory bowel diseases (IBDs). We have investigated the role
of three key RONS-metabolizing enzymes (inducible nitric oxide synthase [iNOS], superox-
ide dismutase [SOD], nicotinamide adenine dinucleotide phosphate [NADPH] oxidase) in a
murine model of IBD. Mice genetically deficient (
 
 
 
/
 
 
 
) in either iNOS or the p47phox subunit
of NADPH oxidase, transgenic (Tg) mice that overexpress SOD, and their respective wild-
type (WT) littermates were fed dextran sulfate sodium (DSS) in drinking water for 7 days to in-
duce colitis. In addition, the specific iNOS inhibitor 1400W was used in DSS-treated WT and
p47phox
 
 
 
/
 
 
 
 mice. WT mice responded to DSS feeding with progressive weight loss, bloody
stools, elevated serum NO
 
X
 
 and colonic mucosal injury with neutrophil infiltration. Both the
onset and severity of colitis were significantly attenuated in iNOS
 
 
 
/
 
 
 
 and 1400W-treated WT
mice. While the responses to DSS did not differ between WT and p47phox
 
 
 
/
 
 
 
 mice, en-
hanced protection was noted in 1400W-treated p47phox
 
 
 
/
 
 
 
 mice. Interestingly, SOD
 
Tg
 
 mice
exhibited more severe colitis than their WT littermates. These findings reveal divergent roles
for superoxide and iNOS-derived NO in intestinal inflammation.
Key words: inﬂammatory bowel diseases • nitric oxide synthase • superoxide dismutase • 
NADPH oxidase • dextran sulfate sodium
 
Introduction
 
Reactive oxygen and nitrogen species (RONS)
 
*
 
 have been
implicated in the pathogenesis of a variety of acute and
chronic inflammatory states, including ischemia-reperfu-
sion injury (1), atherosclerosis (2), rheumatoid arthritis (3)
and inflammatory bowel disease (IBD; e.g., Crohn’s dis-
ease, ulcerative colitis; references 4 and 5). The two most
extensively studied RONS, superoxide (O
 
2
 
·
 
 
 
) and nitric
oxide (NO
 
·
 
), are known to exert profound, and often op-
posing, effects in inflamed tissue. These actions of O
 
·
 
2
 
 
 
 and
NO
 
·
 
 can be manifested as impaired endothelium-depen-
dent vasodilation (6), activation of nuclear transcription
factors, and the subsequent production of inflammatory cy-
tokines (7), enhanced recruitment and activation of leuko-
cytes (8), accelerated apoptosis (9), and parenchymal cell
necrosis (10). Due to the opposing actions of O
 
·
 
2
 
 
 
 and
NO
 
·
 
, which may result from their ability to chemically re-
act with and decompose each other, it is widely held that
conditions which alter the balance between O
 
·
 
2
 
 
 
 and NO
 
·
 
levels may promote inflammation. This concept has lead to
extensive efforts to define the role of RONS in different
 
Address correspondence to D. Neil Granger, Department of Molecular
and Cellular Physiology, LSU Health Sciences Center, 1501 Kings High-
way, Shreveport, LA 71130-3932. Phone: 318-675-6011; Fax: 318-675-
6005; E-mail: dgrang@lsuhsc.edu
 
*
 
Abbreviations used in this paper:
 
 AA, acetic acid; DAI, disease activity
index; DSS, dextran sulfate sodium; IBD, inflammatory bowel disease;
iNOS, inducible NO synthase; MPO, myeloperoxidase; NO, nitric ox-
ide; NADP, nicotinamide adenine dinucleotide phosphate; RONS, reac-
tive oxygen and nitrogen species; SPF, specific pathogen-free; SOD, su-
peroxide dismutase; Tg, transgenic; WT, wild-type. 
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experimental models of inflammation and has stimulated
the search for agents that may alter the production and/or
bioavailability of RONS.
The IBDs are chronic, idiopathic disorders primarily of
the ileum and/or colon that are characterized by abdominal
pain, severe diarrhea, rectal bleeding, and weight loss. In-
volved regions of the bowel often exhibit an intense infil-
tration of leukocytes (including granulocytes and lympho-
cytes), crypt cell hyperplasia, interstitial edema, and
mucosal ulcerations. Accompanying the extensive gut in-
flammation and tissue injury is an enhanced production of
reactive oxygen species such as superoxide, which appears
to be largely generated by membrane-associated nicotina-
mide adenine dinucleotide phosphate (NADPH) oxidase in
activated neutrophils, and a corresponding increase in the
expression of the inducible isoform of NO synthase
(iNOS).
Although several experimental strategies have been em-
ployed to address the importance of the enhanced produc-
tion of superoxide and NO in the pathogenesis of IBD, in-
consistent findings have left this issue largely unresolved.
For example, some reports have described a beneficial ef-
fect of superoxide dismutase (SOD) treatment in experi-
mental models of colitis (11–13), while SOD treatment in
human IBD has shown limited benefit (14). Similarly, in-
hibitors of iNOS have yielded mixed results in various ex-
perimental models of IBD (15, 16) and conflicting results
have been recently reported using mice that are genetically
deficient in iNOS (17, 18). It has been proposed that the
detrimental effects of enhanced NO production by iNOS
are related to the generation of potent oxidants, such as
peroxynitrite. However this concept is currently under de-
bate (19). While the inconsistent findings with RONS-
directed interventions may be attributed to a variety of fac-
tors, such as differences between experimental models, the
specificity and cellular accessibility of agents used to manip-
ulate RONS production and/or bioavailability remains an
important concern. For example, the absence of protection
in animals treated with SOD may reflect an inaccessibility
of the enzyme to the intracellular compartment, rather than
no role for superoxide in the injury process. Furthermore,
the protection afforded by some inhibitors of iNOS in
models of IBD models may reflect a nonspecific action of
these agents on other enzymes or other cellular processes.
Recently, gene targeting technology has led to the pro-
duction of mice that are either selectively deficient in, or
overexpress, candidate mediator proteins, such as cell adhe-
sion molecules, enzymes, or transcription factors. These
mice are rapidly gaining acceptance as a tool for mechanistic
studies of the inflammatory response that obviate some of
the concerns (e.g., specificity) raised about previously em-
ployed interventional strategies. Indeed, the wide variety of
mutant mice that have been produced for inflammation-
related research makes this experimental strategy particu-
larly promising for mechanistic investigations of the patho-
biology of IBD. In the present study, gene-targeted animals
were used to assess the contributions of three key RONS-
related enzymes (iNOS, SOD, and NADPH oxidase) to the
gut inflammation and tissue injury observed in a mouse
model of dextran sulfate sodium (DSS)-induced colitis. The
findings of this study reveal a significant role for both iNOS
and SOD and a minor role for NADPH oxidase in DSS-
induced colitis. The data also indicate divergent roles for
superoxide and iNOS-derived NO, and suggest that NO
derived products other than peroxynitrite may be important
in the pathogenesis of DSS-induced colitis.
 
Materials and Methods
 
Mice.
 
All experimental protocols were applied to either
C57BL/6J-664 (wild-type [WT] control strain) mice (The Jack-
son Laboratory) or mutant mice developed on a C57BL/6 back-
ground strain, at 10–12 wk of age. All experiments were repeated
at least once with 4–5 mice per group. The data displayed are the
combined results of two series of experiments (
 
n
 
 
 
 
 
 4 
 
 
 
 5 
 
 
 
 9/
group), unless otherwise indicated. Some experiments were per-
formed using transgenic (Tg) mice overexpressing human CuZn-
SOD (TgN[SOD1]3Cje) at approximately three times the WT
level as hemizygotes and five times the WT level as homozygotes
(20). Breeder stocks for homozygous C57BL6-TgN(SOD1)3Cje
from a backcross generation 
 
 
 
9 were obtained from The Jackson
Laboratory and used to breed the hemizygous positive Tg mice
(SOD
 
Tg
 
) in our animal care facility. The SOD
 
Tg
 
 mice were iden-
tified by qualitative demonstration of CuZn-SOD activity using
nondenaturing gel electrophoresis followed by nitroblue tetrazo-
lium staining. Some experiments were also performed using mice
deficient in iNOS (C57BL/6-Nos2
 
tm1Lau
 
), which were purchased
from The Jackson Laboratory after 
 
 
 
10 generations of backcross-
ing. An additional series of experiments were performed using
NADPH oxidase deficient (C57BL/6-p47phox
 
 
 
/
 
 
 
) mice devel-
oped by S. Holland, Laboratory of Host Defenses, National Insti-
tutes of Health (21). Breeder stocks for p47phox
 
 
 
/
 
 
 
 mice were
obtained from C. Ross (Kansas State University, Manhattan,
KS). Heterozygote matings were used to produce the homozy-
gous p47phox
 
 
 
/
 
 
 
. For the 1400W study (n 
 
 
 
 5/group), WT-
controls consisted of the p47phox
 
 
 
/
 
 
 
 littermates that resulted
from breeding heterozygous p47phox
 
 
 
/
 
 
 
 mice. The genetic
identity of the p47phox mutants was determined by PCR analy-
sis of DNA in tail clips obtained for each mouse. Since pilot ex-
periments using the same colitis protocol (data not shown)
showed no significant differences for all measured variables be-
tween C57BL/6J-664 mice and p47phox
 
 
 
/
 
 
 
 mice, C57BL/6J-
664 mice were used as WT controls for the remainder of the
study. All groups of animals were singly housed under specific
pathogen-free (SPF) conditions in standard cages and were fed
standard laboratory chow and water ad libidum until the desired
age (10–12 wk) and/or weight (25–30 g). To investigate
whether differences in environment could influence the suscep-
tibility of iNOS
 
 
 
/
 
 
 
 mice to DSS-mediated gut inflammation,
additional groups of iNOS
 
 
 
/
 
 
 
 mice and WT controls were
housed for 2 wk under conventional (nSPF) conditions before
induction of colitis (
 
n
 
 
 
 
 
 5/group). All experimental procedures
involving the use of animals were reviewed and approved by the
Institutional Animal Care and Use Committee of LSU Health
Sciences Center and performed according to the criteria outlined
by the National Institutes of Health.
 
DSS-induced Colitis.
 
Colitis was induced by feeding mice 3%
DSS (mol wt, 40,000; ICN Biomedicals) dissolved in drinking
water (millipore water) for 7 d (22). In pilot experiments, WT
mice were given 3 or 5% (wt/vol) DSS in drinking water for 7 d. 
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Since the mortality rate of mice receiving 5% DSS was nearly
one-third, 3% DSS treatment for 7 d (0% mortality) was chosen as
an optimal dose for detailed analyses. In control mice, normal
drinking water was replaced by millipore water.
 
Treatment with a Specific iNOS-inhibitor.
 
WT and p47phox
 
 
 
/
 
 
 
mice (
 
n
 
 
 
 
 
 5/group) were anesthetized by isoflurane inhalation
(FiO
 
2
 
 0.35 l/l isoflurane, IsoFlo
 
®
 
; Abbott Laboratories). Under
sterile conditions miniosmotic pumps (alzet; ALZA Corp.) were
implanted subcutaneously. They provided a continuous infusion
(1 
 
 
 
l/h) of sterile saline alone (control group) or the specific
iNOS inhibitor 1400W (Cayman Chemical) dissolved in sterile
saline (treated group) and delivered at a rate of 10 mg/kg/h over
the 7 d of DSS treatment (23, 24). 1400W has been shown to in-
hibit human eNOS and nNOS inefficiently, when compared
with its inhibition of iNOS (23). The selectivity ratio of 1400W
for human NOS isoenzymes was reported to be 62 for i-/eNOS
and 4 for i/nNOS (25).
 
Assessment of Inflammation in DSS-treated Mice.
 
Daily clinical
assessment of DSS-treated animals included measurement of
drinking volume and body weight, evaluation of stool consis-
tency, and the presence of blood in the stools by a guaiac paper
test (ColoScreen
 
®
 
; Helena Laboratories [26]). A previously vali-
dated clinical disease activity index (DAI; reference 27) ranging
from 0 to 4 was calculated using the following parameters: stool
consistency; presence or absence of fecal blood; and weight loss.
Mice were killed at day 7, blood was collected by cardiac punc-
ture, and spleens were weighed. Colons were removed; length
and weight were measured after exclusion of the cecum and be-
fore histological and myeloperoxidase (MPO) activity evaluation.
 
Histology.
 
Histological examination was performed on three
samples of distal colon of each animal, which were fixed in Zam-
boni’s solution before embedding in JB-4 (Polysciences) and
staining with hematoxylin and eosin. All histological quantitation
was performed in a blinded fashion using an established scoring
system (28). In brief, three independent parameters were mea-
sured: severity of inflammation; depth of injury; and crypt dam-
age. The score of each parameter was multiplied by a factor re-
flecting the percentage of tissue involvement and added to a sum.
The maximum possible score is 40. In addition, the actual per-
centage of mucosal surface ulcerated was measured by computer-
aided morphometric analysis.
 
Morphometric Analysis.
 
In an attempt to quantify the extent of
ulcerated mucosa, computerized morphometry was performed on
affected sections of each colon of DSS-treated mice by using a
METAMORPH
 
®
 
 image acquisition and processing software sys-
tem (Universal Imaging). Images of three cross-sections of the
distal colonic wall were captured via an ECLIPSE E600 upright
light microscope (Nikon) coupled to a SenSys CCD camera sys-
tem (Roper Scientific Photometrics). The ulcerated mucosal sur-
face was defined by loss of mucosal epithelium and expressed as a
percentage of the total luminal perimeter for each section.
 
Serum TNF Measurements.
 
On day 7 of the protocol, blood
was collected from control and DSS-treated mice for determina-
tion of serum TNF-
 
 
 
 levels by ELISA for murine TNF-
 
 
 
 (detect-
able concentration 
 
 
 
3.0 pg/ml; BioSource International). All cy-
tokine determinations were performed in duplicate serial dilutions.
 
Tissue MPO Activity.
 
Samples included tissue from mid to
distal colon (adjacent to tissue used for histology) and were ob-
tained either from control or DSS-treated animals, rinsed with
cold PBS, blotted dry, and immediately frozen with liquid nitro-
gen. The samples were stored at 
 
 
 
80
 
 
 
C until thawed for MPO
activity determination using the 
 
O
 
-dianisidine method described
previously (29). The change in absorbance was read at 460 nm in
a spectrophotometer (Shimadzu UV-1201 Series; Shimadzu Sci-
entific Instruments). MPO activity was expressed as the amount
of enzyme necessary to produce a change in absorbance of 1.0
per min per gram of wet weight of tissue.
 
Neutrophil Transmigration Assay.
 
WT, iNOS
 
 
 
/
 
 
 
, and
NADPH-oxidase
 
 
 
/
 
 
 
 mice were injected (intraperitoneally with
25 mg of oyster glycogen suspended in 0.5 ml PBS 6 h before
peritoneal lavage with 15 ml PBS containing 10 mmol/L D-glu-
cose (D-PBS). Extravasated leukocytes from at least two mice per
group were pooled, pelleted, and resuspended in 1 ml D-PBS for
quantification before use in the superoxide and NO
 
X
 
 production
assays described below.
 
Measurement of Superoxide Production by PMNs.
 
Superoxide
production rates were determined as described previously (30)
with minor modifications. Briefly, 10
 
6
 
 extravasated neutrophils
were incubated for 30 min at 37
 
 
 
C in the presence of 2 
 
 
 
g/ml
PMA, 1 mg/ml cytochrome c, 30 
 
 
 
g/ml catalase, 
 
 
 
100 
 
 
 
g/ml
SOD in D-glucose phosphate-buffered saline (D-PBS). The cells
were then removed by centrifugation and the absorbance of re-
duced cytochrome c measured at 550 nm. The rate of super-
oxide production was calculated as follows: O
 
2
 
 
 
 (nmol·min
 
–1
 
·10
 
6
 
cells
 
–1
 
) 
 
 
 
 (47.7 
 
  
 
[A
 
–SOD 
 
  
 
A
 
 
 
SOD
 
])/30 min.
 
Measurement of NO Metabolites (NO
 
X
 
) Production by Cultured
PMNs.
 
NO
 
X
 
 production by murine PMNs was measured by
assaying the NO metabolites nitrite and nitrate in the supernatant
of stimulated cells cultured in vitro. Briefly, PMN (10
 
6
 
 cells)
were suspended in 0.5 ml of phenol-free DMEM supplemented
with 1 mM L-arg and 4 mM glutamine, and incubated at 37
 
 
 
C
for 24 h in the presence of 10 U/ml recombinant murine IFN-
 
 
 
(R&D Systems) and 1 
 
 
 
g/ml LPS (serotype O55:B5; Sigma-
Aldrich). Cells were removed by centrifugation and the superna-
tant collected. NO
 
X
 
 levels in collected supernatants were deter-
mined using the standard Griess reaction and the results expressed
as 
 
 
 
M total NO
 
X
 
.
 
Measurement of Serum NO
 
X
 
.
 
Additional groups of WT,
SOD
 
Tg
 
, and iNOS
 
 
 
/
 
 
 
 mice plus the p47phox /  mice with their
WT controls from the 1400W study (n   5/DSS-treated group,
n    3/H2O-treated group) were fasted 16 h before exsan-
guination. Blood was collected in microtainer serum separator
tubes (Microtainer; Becton Dickinson). After clotting of blood
on ice, samples were centrifuged and the supernatant serum col-
lected. Serum samples were then passed through a size exclusion
column (Ultrafree-MC 10,000 MW exclusion; Millipore Corpo-
ration) to remove free hemoglobin and the resulting ultrafiltrate
assayed for total NOX using a modification of the standard Griess
assay described previously (31).
Data Analysis. Statistical analyses were performed with Stat-
View 4.5v software (Abacus Concepts) using a one-way ANOVA
followed by Scheffé’s (post hoc) test for parametric or the
Kruskal-Wallis test for nonparametric data. All values are reported
as means   SEM. Statistical significance was set at P   0.05.
Results
Neither a Genetic Deficiency of iNOS, p47phox (NADPH
Oxidase) nor Overexpression of SOD Changed Gross Gas-
trointestinal Morphology or Function. None of the untreated,
genetically engineered mice used in this study exhibited
any of the clinical signs (diarrhea, rectal bleeding, weight
loss) normally associated with spontaneous intestinal in-
flammation. Furthermore, gross examination of the gas-
trointestinal tract from untreated iNOS / , p47phox / ,1210 Reactive Oxygen and Nitrogen Species in Intestinal Inflammation
and SODTg mice did not reveal any evidence of inflamma-
tory changes in the gut.
Serum TNF-  Was not Altered on Day 7 of Colitis.
ELISA of serum samples (n   8/group) revealed no signifi-
cant change in TNF-  levels in any of the DSS-treated
groups when compared with controls (values ranging from
0 to 127 pg/ml).
Genetic Deficiency in iNOS Expression Attenuated Clinical
Abnormalities Induced by DSS Colitis. DSS treatment of
WT mice for 7 d was associated with significant changes in
body weight starting on day 5 (Fig. 1) and the appearance
of fecal blood on day 4 (Fig. 2). Only mild alterations were
seen in stool consistency and no mortality was observed.
Drinking volume was similar in all groups (data not
shown). DAI scores in DSS-treated mice were lowest in
the iNOS /  mice compared with WT controls (signifi-
cant from day 4 to day 7; Fig. 3).
Tg Overexpression of SOD Exacerbated the Clinical Abnor-
malities Associated with DSS-induced Colitis. The clinical
score was highest in the SODTg mice receiving DSS (Fig.
3) reaching statistical significance when compared with the
WT mice from day 4 to 7.
Genetic Deficiency in p47phox Did not Influence Susceptibility
to DSS-induced Colitis. Throughout the 7 d of DSS ad-
ministration, the clinical score for p47phox /  mice re-
mained unchanged from WT mice (Fig. 3). These results
are in contrast to the attenuated disease activity noted in
mice lacking iNOS, and the more pronounced disease in
SOD Tg mice.
iNOS Deficiency Attenuates, while SOD Overexpression Ex-
aggerates, the Macroscopic Changes Associated with DSS Admin-
istration. DSS-treated WT mice exhibited the macro-
scopic changes, which are classically associated with this
model of colitis. These changes included shortening of the
colon and increases in weight of the colon and spleen (Ta-
ble I). In DSS-treated iNOS /  mice however, no increase
in spleen weight was noted and colonic shortening and
weight increase were both significantly attenuated. Com-
Figure 1. Clinical score (DAI) over 7 d after water in WT or DSS oral
treatment in WT, iNOS / , p47phox / , and SODTg mice (n   9/
group). a versus WT plus water; b versus WT plus DSS; c versus iNOS / 
plus DSS; d versus p47phox / ; and e versus SODTg plus DSS. Mean  
SEM. P   0.05.
Figure 2. Body weight change from 100% baseline over 7 d after water
in WT or DSS oral treatment in WT, iNOS / , p47phox / , and
SODTg mice (n   9/group). a versus WT plus water; b versus WT plus
DSS; c versus iNOS /  plus DSS; d versus p47phox / ; and e versus
SODTg plus DSS. Mean   SEM. P   0.05.
Figure 3. Rectal bleeding score over 7 d after water in WT or DSS
oral treatment in WT, iNOS / , p47phox / , and SODTg mice (n   9/
group). a versus WT plus water; b versus WT plus DSS; c versus iNOS / 
plus DSS; d versus p47phox / ; and e versus SODTg plus DSS. Mean  
SEM. P   0.05.1211 Krieglstein et al.
pared with DSS-treated WT mice, SODTg mice showed a
significant increase in spleen weight whereas colon length
and weight remained unchanged. DSS-associated macro-
scopic changes in the colon were unaltered in p47phox / 
mice. Consistent with the observed clinical scores, SODTg
mice exhibited the most aggressive injury, with an un-
changed injury response in p47phox /  and a blunted in-
jury response in DSS-treated iNOS /  mice.
Histologic Assessment Confirmed the Protection against DSS-
induced Colitis by iNOS Deficiency and the Exaggerated Disease
Response with SOD Overexpression. Blinded histologic in-
jury scoring was quantified in the distal colon from WT,
iNOS / , p47phox / , and SODTg mice (9/group) after
7 d of treatment with DSS 3%. Resulting colonic inflamma-
tion was mostly confined to the mucosa with loss of goblet
cells, crypt damage, mucosal ulceration, and accompanying
edema of the submucosa. Mucosal ulceration was signifi-
cantly decreased (63.5%) in iNOS /  mice (Table II). The
severity of colitis was also significantly attenuated (36.5%)
in iNOS /  versus WT mice (Table II). Crypt damage in
SODTg mice was significantly worse (1.6-fold) compared
with WT mice. The total histologic score (Table II) was
lowest in iNOS /  (12.0   1.5) and highest in SODTg
mice (23.9   1.3), each exhibiting a significant difference
Table I. Inflammatory Changes in Colon and Spleen after DSS Administration
Colon length Colon weight/length ratio Spleen weight
cm mg/cm % body weight
WT plus water 7.3   0.2b–e 35.9  1.7b–e 0.31   0.02b, e
WT plus DSS 4.8   0.2a, c 65.9   3.5a, c 0.54   0.04a, c
iNOS /  plus DSS 5.9   0.2a, b, e 51.3   2.1a, b 0.33   0.02b, e
p47phox /  plus DSS 5.3   0.1a 59.5   4.8a 0.39   0.05e
SODTg plus DSS 4.7   0.2a, c 62.6   2.2a 0.65   0.05a, c, d
WT (conv.) plus DSS 5.2   0.3 58.0   4.6 0.51   0.06
iNOS /  plus DSS 6.4   0.3f 45.4   4.2f 0.30   0.03f
Colon and spleen changes after 7 d of oral treatment with either water in WT or DSS in WT, iNOS / , p47phox / , and SODTg mice (n  
9/group). In addition DSS-treated WT versus iNOS /  mice under conventional housing conditions (n   5/group). Mean   SEM.
aP   0.05 vs. WT plus water.
bP   0.05 vs. WT plus DSS.
cP   0.05 vs. iNO /  + DSS.
dP   0.05 vs. p47phox /  plus DSS.
eP < 0.05 vs. SODTg plus DSS. 
fP   0.05 vs. WT (conv.) plus DSS.
Table II. Histologic Alterations after DSS Administration
Total histology score Crypt damage Severity of colitis
Ulcerated
surface
score score score %
WT plus DSS 17.9   0.7b, d 6.7   0.4b, d 7.4   0.3b 20.3   1.8b
iNOS /  plus DSS 12.0   1.5a, d 4.4   0.6a, d 4.7   0.7a, d 7.4   0.8a, c, d
p47phox /  plus DSS 16.3   1.4d 6.9   0.6d 6.1   0.7d 15.9   2.3b
SODTg plus DSS 23.9   1.3a–c 10.4   0.8a–c 9.1   0.5b, c 22.0   2.0b
WT (conv.) plus DSS 18.8   1.6 7.1   0.5 7.8   0.5 22.8   3.5
iNOS /  (conv.) plus DSS 11.4   2.0e 3.9   1.7e 4.3   0.9e 6.2   2.7e
Blinded histologic assessment of colitis after oral treatment with DSS for 7 d in WT, iNOS / , p47phox / , and SODTg mice (n   9/group). In
addition DSS-treated WT versus iNOS /  mice under conventional housing conditions (n   5/group). Based on validated scoring system and
morphometry described in Materials and Methods. Mean   SEM.
aP   0.05 vs. WT.
bP   0.05 vs. iNOS / .
cP   0.05 vs. p47phox / .
dP   0.05 vs. SODTg.
eP   0.05 vs. WT (conv.).1212 Reactive Oxygen and Nitrogen Species in Intestinal Inflammation
from WT mice (17.9   0.7). Histologic findings in
p47phox /  mice were unchanged from their WT con-
trols. These observations are consistent with the macro-
scopic findings (Table I) and further support the conclusion
that susceptibility to DSS-induced colonic injury is de-
creased in iNOS / , increased in SODTg and unchanged in
p47phox /  mice.
Neutrophil Recruitment into the Colon during DSS Colitis
Was Attenuated in the Absence of iNOS and Is Exaggerated by
Overexpression of SOD. DSS administration was followed
by a significant increase in MPO activity in all mice (Fig.
4). MPO activity corresponded closely with the clinical and
histological grading of inflammation in the different groups
(Figs. 1–3 and Table I). Whereas WT and p47phox / 
mice showed approximately equivalent increases in MPO
activity (14-fold and 13-fold, respectively), the increment
in colonic MPO was significantly less pronounced (7.4-
fold) in iNOS /  mice, but more pronounced in SODTg
mice (23-fold) after DSS administration (Fig. 4).
Treatment of WT Mice with the Specific iNOS Inhibitor
1400W Attenuated DSS-induced Colitis. When compared
with saline-treated controls the 1400W-treated WT mice
lost significantly less weight (11.6   1.8% versus 6.1  
0.9%, respectively), and exhibited minimal rectal bleeding
that was detectable only by testing for fecal occult blood,
whereas all controls exhibited gross rectal bleeding. Daily
measurements of the DAI demonstrated the delayed and at-
tenuated clinical course of colitis after blockade of iNOS
by 1400W (Fig. 5), which resulted in less tissue damage as
summarized in Table III.
Blockade of iNOS by 1400W in p47phox–deficient Mice Re-
vealed an Additional Role for NADPH-Oxidase in DSS-induced
Colitis. Saline-treated p47phox /  mice and their saline-
treated WT controls showed no differences in the onset
and severity of DSS colitis and associated tissue damage
(Fig. 5, Table III). However continuous treatment of
p47phox /  with the specific iNOS inhibitor 1400W re-
sulted in protection that was not only significant when
compared with the saline-treated p47phox /  control
mice, but was also superior to the protection achieved by
treatment of WT mice with 1400W (P   0.05). Indeed,
40% of 1400W-treated p47phox /  mice did not exhibit
rectal bleeding whereas all 1400W-treated WT mice were
positive for fecal blood. Weight loss after 7 d of DSS ad-
ministration was significantly reduced in 1400W-treated
p47phox /  mice (0.1   0.6%) when compared with sa-
line-treated p47phox /  (12.4   1.3%) and to 1400W-
treated WT mice (6.1   0.9%). Colonic shortening and
histology confirmed the superior protective effect of com-
bined pharmacologic iNOS blockade and p47phox defi-
ciency (Table III).
Stimulated p47phox /  PMNs Generated More NOX Com-
pared with WT (control) PMNs, Whereas O2
  Production by
iNOS /  PMNs Was not Significantly Different from WT
(Control) PMNs. 24 h after stimulation, PMNs from
p47phox /  mice produced almost five times more NOX
than PMNs of their WT controls (188.6   26.3 versus
37.8   2.2  M). NOX production by unstimulated PMNs
Figure 4. MPO in colonic tissue of water-treated WT mice or after 7 d
of treatment with DSS in WT, iNOS / , p47phox / , and SODTg mice
that were housed under SPF conditions (n   9/group) or WT and iNOS
mice housed under conventional condition (n   5/group). Tissue con-
centrations were measured by the O-dianisidine method. The change in
absorbance was read at 460 nm in a spectrophotometer. MPO activity
was expressed as the amount of enzyme necessary to produce a change in
absorbance of 1.0 per min per gram of wet weight of tissue. Mean  
SEM. *P   0.05 vs. water-treated WT. #P   0.05 vs. DSS-treated WT.
Figure 5. Clinical score (DAI) during 7 d of DSS administration in
WT and p47phox /  mice that received concomitant 1400W (or saline
in controls) using a subcutaneously implanted miniosmotic pump (n  
5/group). a versus WT saline plus DSS, b versus p47phox /  1400W plus
DSS, c versus p47phox /  saline plus DSS. Mean   SEM. P   0.05.1213 Krieglstein et al.
did not differ between p47phox /  and WT mice (Fig. 6).
The production of superoxide by PMNs was similar in
iNOS /  PMNs and WT (control) PMNs (1.4   0.1 ver-
sus 1.6   0.1 nmol.min 1.106 cells 1, respectively).
DSS Colitis Was Characterized by Elevated Serum NOX Lev-
els that Were Dependent on iNOS Activity. DSS administra-
tion in drinking water over 7 d resulted in a 250% increase
of serum NOX in WT mice when compared with controls
given millipore water. Serum levels of NOX after DSS
were significantly lowered by either genetic deletion of
iNOS ( 75.1%) or blockade of iNOS using 1400W (up to
 57.8%). Interestingly, serum NOX in DSS-treated SODTg
was 33% higher compared with DSS-treated WT, however
this change did not achieve statistical significance. No dif-
ferences were found between WT and p47phox /  mice
after saline pump implantation and DSS administration. As
expected, the lowest serum NOX levels were detected in
DSS-treated iNOS /  (Fig. 7).
Protection against DSS-induced Colitis by iNOS Deficiency
Did not Depend on SPF Housing Conditions. The same his-
topathologic changes that were observed in DSS-treated
mice housed under SPF conditions were also present in
subsets of WT and iNOS /  mice housed under conven-
tional conditions before the experiment (Tables I and II).
In addition, the attenuated clinical course of DSS colitis
observed in iNOS /  mice under SPF conditions was
present under conventional conditions (data not shown).
Discussion
The objectives of this study were to assess the contribu-
tion of RONS-regulating enzymes in the acute phase of
DSS-induced colitis by using gene-targeted mice that are
genetically deficient in either iNOS or functional NADPH
oxidase (p47phox), or which overexpress CuZn-SOD.
The role of iNOS was further assessed using the specific
iNOS inhibitor, 1400W. Our findings indicate that either
the genetic absence or pharmacologic blockade of iNOS
significantly attenuates the severity of colonic inflammation
Table III. Effects of a Specific iNOS Inhibitor on the Development of DSS Colitis
Colon
length Histology
MPO
activity
cm score U/g colon
WT saline plus DSS 5.1   0.31 19.8   1.7 21.1   1.5
WT 1400W plus DSS 6.6   0.3a 10.8   1.4a 10.6   2.8a
p47phox /  saline plus DSS 5.0   0.1 19.2   3.4 20.3   2.5
p47phox /  1400W plus DSS 7.9   0.2b, c 1.8   0.8b, c 5.2   1.7c
WT plus DSS 4.8   0.2 17.9   0.7 19.0   2.5
iNOS /  plus DSS 5.9   0.2d 12.0   1.5d 9.9   2.0d
Effects of treatment with 1400W on susceptibility to DSS-induced colitis in WT and p47phox /  mice (n   5/group). 1400W (or saline in controls)
was administered over 7 d using a subcutaneously implanted miniosmotic pump parallel to feeding DSS in drinking water. To facilitate how the
iNOS /  compound compared in relation to 1400W-treated mice the result of DSS administration to iNOS /  mice and their appropriate controls
is shown as a subsection of this table.
aP   0.05 vs. WT saline plus DSS.
bP   0.05 vs. WT 1400W plus DSS.
cP   0.05 vs. p47phox /  saline plus DSS.
dP   0.05 vs. WT plus DSS.
Figure 6. Effect of stimulation (recombinant murine INF-  10 U/ml
and LPS 1  g/ml) of PMNs of WT and p47phox /  mice on the pro-
duction of NOX in vitro. NOX levels in the medium were assayed 24 h
after incubation with the inflammatory mediators. PMNs of at least two
mice per group were pooled and analyzed in triplicates. Concentrations
were measured using a modification of the standard Griess assay and ab-
sorbances were read at 540 nm in a spectrophotometer. Results are ex-
pressed as  M NOX. Mean   SEM. *P   0.05 vs. unstimulated WT
PMNs. #P   0.05 vs. stimulated WT PMNs.1214 Reactive Oxygen and Nitrogen Species in Intestinal Inflammation
in DSS-induced colitis, a model that involves epithelial cell
injury (27). On the other hand, mice that genetically over-
express CuZn-SOD exhibited exaggerated inflammatory
and tissue injury responses to DSS treatment. The absence
of functional NADPH oxidase, resulting from targeted dis-
ruption of p47phox, did not alter susceptibility to DSS-
induced intestinal inflammation provided that iNOS re-
mained functional. Using the specific iNOS inhibitor
1400W, we demonstrated that the combined blockade of
iNOS (by 1400W) and NADPH oxidase (by genetic dele-
tion of p47phox) was even more effective in protecting
mice from DSS-colitis than either intervention alone.
These results suggest that both iNOS and CuZn-SOD play
an important role in the progression of DSS-induced coli-
tis. NADPH oxidase per se may only play a minor role in
the presence of functional iNOS since genetic blockade of
this enzyme alone did not influence the course of colitis.
The data derived from iNOS /  mice and 1400W-
treated WT mice exposed to DSS suggest that iNOS-
derived NO either directly or indirectly contributes to the
initiation and/or progression of inflammation and tissue in-
jury. This contention is supported by previous reports that
demonstrate increased iNOS activity and NO production
by epithelial cells and leukocytes harvested from colonic
specimens derived from humans or rodents with colitis (17,
32, 33). Furthermore, the fact that a similar protection
from DSS colitis was achieved by treatment of WT mice
with either 1400W or genetic disruption of iNOS sup-
ports a proinflammatory role for iNOS. Our findings are
consistent with several studies showing attenuated colonic
injury in different models of IBD treated with iNOS in-
hibitors given in the drinking water (15, 34, 35). How-
ever, our results in iNOS /  mice contrast with recently
published reports that employed these same mutants in
the trinitrobenzene sulphonic acid (TNBS/ETOH; refer-
ences 17 and 18) and acetic acid (AA; reference 33) mod-
els of colonic injury and inflammation. The results of the
TNBS/ETOH studies were inconsistent since iNOS-
deficient mice were shown to exhibit an exaggerated
course of the acute phase of TNBS/ETOH colitis in one
study (17) and an attenuated course in the other study
(18). A notable difference between these studies was the
housing environments of the mice. The iNOS /  mice
showing protection were housed under SPF conditions
(18) whereas the others were conventionally housed (17).
The greater sensitivity of iNOS /  to a number of patho-
gens was proposed as a possible explanation for the in-
creased susceptibility to TNBS/ETOH-induced colitis af-
ter conventional housing.
SPF-housed mice harbor indigenous microflora ( 500
species) as do conventional mice. Since SPF mice are kept
in a clean controlled environment, they do not acquire ad-
ditional opportunistic pathogens, such as Salmonella or
Pseudomonas that could alter the experimental results.
Therefore, “clean” SPF-housed mice may be more rele-
vant to human disease than “dirty” conventionally housed
mice. In our experimental model, conventional or SPF
conditions did not influence the outcome of colitis in
iNOS /  mice. The study using iNOS /  in AA-induced
colitis showed a reduced ability to repair colitis-associated
tissue injury (38), when compared with WT mice.
There are fundamental differences between the DSS
model of colitis and both the TNBS/ETOH and AA mod-
els that may account for the differential responses of iNOS-
deficient mice. The use of AA and TNBS/ETOH to in-
duce epithelial injury represents an acute and massive insult
that occurs within 30 min after intrarectal administration
(36). The protective effect observed in TNBS/ETOH-
treated iNOS /  mice was limited only to the first 24 h
and absent at 72 h after the inflammatory stimulus (17). In
the DSS model used in our study, colitis develops gradually
in response to continuous administration (7 d) of an inflam-
matory stimulus. Attenuation of clinical symptoms in DSS-
treated iNOS /  mice was not statistically significant until
day 4 and MPO activity was not measured until day 7 of
inflammation, since neutrophils do not accumulate to a sig-
nificant degree at an earlier stage. Different pathophysio-
logical mechanisms may be involved in tissue repair after a
single insult when compared with a continuous insult.
Therefore, we propose that part of the controversy regard-
ing whether iNOS /  mice are more or less susceptible to
colonic inflammation may relate to differences in the
pathogenic mechanisms that underlie TNBS/ETOH-,
AA-, and DSS-induced colitis.
Figure 7. NOX levels in serum of different mutant and WT mice that
received DSS in drinking water over 7 d or millipore water (H2O) in
controls (n   5/DSS-treated group; n   3/H2O-treated group). Serum
concentrations were measured using a modification of the standard Griess
assay and absorbances were read at 540 nm in a spectrophotometer. Re-
sults are expressed as  M NOX. Mean   SEM. *P   0.05 vs. H2O-
treated WT. #P   0.05 vs. DSS-treated WT. ‡P   0.05 vs. saline-pump.1215 Krieglstein et al.
An enhanced iNOS-dependent production of NO may
modify inflammation by one or more mechanisms, thereby
leading either to an improvement or exacerbation of in-
flammation. iNOS /  mice may be protected against DSS-
induced colitis because of decreased production of the
highly cytotoxic oxidant ONOO , which results from the
interaction between NO and O·
2
  (37). This mechanism
however seems unlikely in view of our results in SODTg
mice and p47phox / , where a reduction in O·
2
  produc-
tion (p47phox / ) or accumulation (CuZn-SODTg) would
be expected to decrease ONOO  formation and thus de-
crease colonic injury and inflammation. Indeed, the un-
changed susceptibility of p47pox /  mice to DSS treat-
ment and the additional protection afforded by p47phox
deletion that was only detectable after iNOS blockade (us-
ing 1400W) support the theory that phagocyte-derived re-
active oxygen metabolites play little or no role in the pres-
ence of iNOS in DSS colitis (38).
The observation that the combination of iNOS blockade
(by 1400W) and nonfunctional NADPH oxidase (by ge-
netic deletion of p47phox) resulted in additional protection
may be explained by the scavenging properties of NO. It is
known for example that NO can directly inhibit NADPH
oxidase and thereby limit superoxide generation (39). Sup-
pression of NO production (induced by 1400W treatment)
and the resultant enhancement of NADPH oxidase func-
tion may therefore account for the more severe inflamma-
tion noted in 1400W-treated WT mice, compared with
1400W-treated p47phox /  mice. P47phox-independent
production of reactive oxygen intermediates must also be
considered as a reason why p47phox /  mice did not show
protection when compared with their WT controls. How-
ever, the additional protection that can be achieved by
p47phox deletion in 1400W-treated mice does not support
this possibility. It would be interesting to determine
whether similar results could be achieved in mice that are
doubly deficient in both enzymes (p47phox / /iNOS / ).
Unfortunately, p47phox / /iNOS /  mice form massive
abscesses containing mostly enteric bacteria, even when
reared under SPF conditions with antibiotics whereas nei-
ther parental strain shows such infections (40). Thus,
p47phox compensates for a deficiency in iNOS and vice
verse thereby providing resistance to indigenous bacteria.
We were able to demonstrate that iNOS-deficient
PMNs can produce superoxide and that p47phox-defi-
cient PMNs can generate NO. Therefore, it is also possi-
ble that p47phox /  mice can compensate for the loss of
phagocytic activity from reactive oxygen species by gener-
ating larger amounts of reactive nitrogen species. Our
finding that p47phox /  PMNs generated significantly
more NOX when compared with WT control PMNs 24 h
after LPS/IFN-  stimulation further supports this hypoth-
esis. The fact that iNOS deficiency only results in partial
protection, while combined blockade of iNOS and
NADPH oxidase offers nearly complete protection sug-
gests that compensatory mechanisms may exist that allow
NO and superoxide to replace each other’s proinflamma-
tory activity. Similar compensatory responses have been
described in studies that examine the role of RONS in mi-
crobicidal processes (40).
Another interesting finding in the present study is that
neutrophils from phox47 /  animals produced more NO
than their wt counterparts, but total animal NO production
did not differ between the groups (Figs. 6 and 7). Our data
does not allow for resolution of this issue, however, it
should be noted that the method for stimulating NO pro-
duction differed for the two measurements (in vitro LPS/
IFN-  versus in vivo DSS). Furthermore, there are sources
of iNOS-derived NO other than PMNs present in vivo
(i.e., macrophages), which may contribute to serum NO,
whereas the in vitro experiments specifically addressed
PMN-derived NO production.
Another possible mechanism by which iNOS-derived
NO could mediate colonic inflammation and injury is
through the production of nitroxyl anions (NO , refer-
ence 41). NO  is a potent cytotoxic agent (42–44) that has
been reported to be up to 1,000  more toxic than NO·
(42). The absence of NO  formation in iNOS /  mice or
after 1400W treatment could protect these mice against
the relatively severe form of DSS colitis that is seen in WT
control mice.
An altered response of the gut microvasculature to DSS-
induced injury in the absence of iNOS could also explain
our findings. This is supported by recently published data
showing that microvascular reactivity and permeability of
the mesenteric vascular bed were altered to a lesser degree
in iNOS /  mice after topical or systemic challenge with
bacterial endotoxin, compared with the responses observed
in their wt littermates (6). Also the residual mucosal injury
observed in iNOS /  mice suggests other significant
mechanisms that are NO independent.
The exaggerated DSS-induced inflammation that we ob-
served in SODTg mice was unexpected since SOD is
known to protect tissues against inflammation-mediated in-
jury. The antiinflammatory properties of SOD, which re-
late to the enzyme’s ability to eliminate superoxide, have
been demonstrated in a variety of experimental models (11,
45). Furthermore, SOD treatment has proven to be some-
what effective in the treatment of patients with Crohn’s
disease (14). This enzyme catalyzes the dismutation of O·
2
 
to H2O2 and molecular oxygen. Virtually all eukaryotic
cells contain SOD in one or more isoforms, CuZnSOD in
the cytoplasm and MnSOD in mitochondria. The SOD-
catalyzed reaction is 10,000 times faster than the spontane-
ous dismutation of O·
2
 , thus O·
2
  levels are usually kept
very low (46). The H2O2 generated by SOD is also re-
moved enzymatically by catalase, which is particularly effi-
cient at high concentrations of H2O2 and catalyses the
detoxication of H2O2 to water and molecular oxygen. Al-
though some investigators have suggested that SOD over-
expression may produce enhanced amounts of H2O2 and
thus may promote rather than attenuate inflammation (47).
This appears highly unlikely since it is well appreciated that
the amount of H2O2 generated by SOD-catalyzed dismuta-
tion will be identical to the amount produced by the spon-
taneous dismutation of O2
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explanation for the results obtained with SODTg mice is
that overexpression of SOD may enhance NF- B activa-
tion (49). Although NF- B may be indispensable as an in-
ducer of many immediate-early inflammatory and immune
genes, it is probably harmful or even fatal in diseases and
syndromes that involve an aberrant expression of inflam-
matory cytokines, such as colitis. This hypothesis is further
supported by a recently published study showing increased
colonic NF- B DNA-binding activity in DSS-induced
colitis. Furthermore suppression of NF- B by gliotoxin
protected mice from DSS-colitis, which underscores the
essential role of NF- B in DSS-induced colitis (50). In ad-
dition, iNOS expression in experimental colitis can be
down regulated by blockade of NF- B activity using pro-
teasome inhibitors (51).
Another explanation for the exaggerated inflammatory
responses in CuZn-SODTg mice relates to the ability of
SOD to chemically reduce NO to yield the cytotoxic and
proinflammatory NO  (52). Since iNOS /  mice were
protected against DSS colitis, we postulated that NO de-
rived from inducible NOS may be an important mediator
of inflammation. Therefore, one might expect that toxic
amounts of NO·-derived nitroxyl could accumulate in the
colon of DSS-treated SODTg mice and the nitroxyl may be
responsible for the exacerbated colonic injury observed in
these animals. In this context, our results in SODTg mice
provide additional support for the hypothesis that NO
plays an important role in the progression of DSS-related
tissue injury.
There is also evidence that overexpression of CuZn-
SOD can impair the microbicidal and fungicidal activity of
macrophages (53). This impaired macrophage function
was associated with decreased NF- B activation and re-
duced NO production. In the previously mentioned
study, it was also shown that activated macrophages from
Cu/Zn-SOD Tg mice produced significantly more H2O2
than their wt counterparts (54). This may explain why
high concentrations of SOD are toxic in a model of car-
diac ischemia-reperfusion injury, a response that is pre-
vented by catalase (55). In view of these findings, one
might expect overexpression of Cu/Zn-SOD to decrease
the host’s ability to defend against invading bacteria in the
gut. Mucosal CuZn-SOD activity appears to be reduced
in humans with Crohn’s disease and unchanged in ulcer-
ative colitis (56).
MPO activity has been shown by others to be propor-
tional to the number of neutrophils in the inflamed tissue
(57). In this study, it was demonstrated that MPO activity
is strongly associated with the colonic tissue injury result-
ing from DSS administration in the different study groups,
suggesting that RONS may be important in the signaling
process for neutrophil recruitment. There is also good evi-
dence that leukocytes and possibly neutrophils contribute
significantly to the DSS-associated tissue injury since oth-
ers have demonstrated that intercellular adhesion molecule
1–deficient mice exhibit an attenuated injury response in
the same model of murine colitis (58). However, it re-
mains unclear, whether neutrophils act as direct mediators
of DSS-injury or their recruitment is secondary to DSS-
induced damage.
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